Biotech Fund Dumps Million: What It Signals for Investors
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
What Does Spx Level Tell You About Market distills the level into actionable insights about market breadth and momentum.
28,520 articlesA major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Aveanna's Q1 2026 results shed light on how the company is navigating labor costs, payer mix, and geographic expansio...
A 67-year-old retiree can add roughly $50,000 a year from self-employment without reducing Social Security benefits, ...
This article breaks down BRO's Q1 2026 earnings, highlights the key drivers behind growth, and offers practical steps...
February delivered a sharp 21.4% drop for BigBear.AI, widening concerns about AI stocks. This guide breaks down the d...
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
The news that Innodata’s founder sold a large chunk of shares is sending ripples through the market. This article bre...
Tenable’s stock jumped on Monday, marking a sharp continuation of a rally that started in the spring. This article di...
IWM holders confront higher annual fees and a recurring reconstitution drag that can erode returns. Cheaper small-cap...
Could Amazon pull ahead of the broader market? This article builds a disciplined case for why Amazon might outperform...
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...